417
Participants
Start Date
August 31, 2009
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
Dapagliflozin
once daily, 12 weeks
Placebo
once daily, 12 weeks
Research Site, Anjyo
Research Site, Bunkyō City
Research Site, Chūōku
Research Site, Daitō
Research Site, Kamagaya
Research Site, Kashiwara
Research Site, Matsuyama
Research Site, Nagoya
Research Site, Naka
Research Site, Nakano
Research Site, Nerima-ku
Research Site, Okinawa
Research Site, Osaka
Research Site, Sapporo
Research Site, Shibuya-ku
Research Site, Shinjyuku-ku
Research Site, Suita
Research Site, Uji
Research Site, Wakayama
Research Site, Yamato
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
AstraZeneca
INDUSTRY